OMEROmeros Corporation

$835M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$36M

Net Income

-$34M

EPS (Diluted)

$-0.54

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

$175M

Free Cash Flow

$175M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$560M

Total Liabilities

$505M

Stockholders' Equity

$55M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$36M	-$35M	-1.9%
Net Income	-$34M	-$33M	-2.1%

OMER Q1 2023 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena